Tariff Shock Hits Pharma; Nifty Extends Losing Streak

Hello ,

Six-Day Slide Deepens as Pharma & IT Lead Selloff

📰 Market Overview

Indian equities endured another rough session, with the Nifty 50 slipping 236 points to 24,654 and the Sensex tumbling 733 points to 80,426. This marks the sixth consecutive day of decline, wiping out nearly ₹7 lakh crore in investor wealth. Mid- and small-cap indices fell even harder, both down over 2%, underscoring the depth of selling pressure.

The trigger came from the U.S. imposing 100% tariffs on branded drugs, sparking a rout in pharma names, while IT stocks slumped on weak global cues and visa worries. Every major sectoral index ended in the red.

🏦 Sectoral Pulse

• Pharma: Tanked ~2.4% after U.S. tariff shock.

• IT/Tech: Dragged lower by weak outlook and visa uncertainties.

• Banks & Financials: Witnessed heavy profit-booking; SBI, IndusInd, and others slipped.

• Consumer Durables, Capital Goods, Infra, Metals: All extended losses, confirming broad weakness.

• Relative Outperformers: Select cyclicals and large diversified names (Reliance, L&T) held up better.

🚀 Top Movers

Nifty 50 – Gainers

• L&T, Tata Motors, Eicher Motors, Reliance Industries, ITC managed small gains despite the selloff.

Nifty 50 – Losers

• M&M: ▼ ~4%

• Sun Pharma: ▼ ~5%

• Eternal, Tata Steel, IndusInd Bank also dropped sharply.

Nifty 500 – Broader Market

• Heavy selling across mid and small caps, with pharma, IT, and export-oriented names hardest hit.

• Few defensives and select PSU stocks provided minor cushion.

🔎 What It Means for Investors

The six-day slide signals that risk appetite has turned fragile. The U.S. tariff escalation is a major negative for pharma exporters, while IT faces external headwinds too. Weakness across sectors points to rising caution among both domestic and foreign investors.

For retail portfolios, this is a reminder to:

• Stay balanced with quality large-caps.

• Avoid chasing momentum in vulnerable sectors.

• Use volatility for staggered entry into long-term themes.

🗝 Key Takeaway

The combination of policy shocks, global uncertainty, and profit booking has dragged the market lower in a broad-based fashion. With the Nifty below 24,700, investors should brace for more volatility ahead. Patience and selective positioning will be key until clarity emerges on trade and earnings.

We’re excited to share that the September Cohort is now officially open for subscription – but only for a limited period!

This is your chance to join GoalFi’s factor-based, research-driven portfolios and align with a fresh strategy for the new month.

⚡ Updated research
⚡ Tactical allocations
⚡ Same GoalFi edge

Don’t miss the window - secure your spot in the September Cohort today.

👉 Subscribe Now
📩 To join, simply message us at 👉 chat.goalfi.app

✨ A New Chapter at GoalFi 

We’ve launched Stock Research Advice – your tactical edge for swing trades, positional strategies, and smarter risk management.

👉 Exclusive to GoalFi Smallcase subscribers. Learn more: goalzencapital.in

📢 GoalFi Announcement

We’re expanding our GoalFi WhatsApp Community for our valued subscribers!

If you’re a subscriber but not yet part of the community, we’d be happy to welcome you in.

Get access to:
✔️ Daily research updates
✔️ Market insights
✔️ Live alerts
✔️ Direct analyst communication

📩 To join, simply message us at 👉 chat.goalfi.app

Let’s build smarter investing habits, together.
https://goalfiresearch.smallcase.com

We hope this update helps you stay informed and empowered in your investment journey. Feel free to reach out if you have any questions or need personalized advice.

Best Regards,
Team GoalFi

Disclosures: https://goalfiresearch.smallcase.com/#disclosures

Disclaimer: This newsletter is intended solely for educational and informational use. It does not constitute financial advice or serve as a promotional message.